{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-201408","form_type":"8-K","ticker":"ELOX","cik":"0001035354","company_name":"Eloxx Pharmaceuticals, Inc.","filed_at":"2026-05-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:31.838915+00:00","generated_at":"2026-05-15T00:12:16.582873+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Stockholders approve reverse split range, authorized share reduction, equity plan amendments via written consent","bullets":["Ratified amendment to 2018 Equity Plan: shares available increased to 20M, ISO limit to 30M.","Approved restated plan extending ISO grant period, further raising ISO limit, extending evergreen provision.","Approved reverse stock split at ratio 1:2 to 1:20, with board discretion for up to one year.","Approved decrease in authorized common shares from 500M to 100M, effective at board discretion within one year.","Votes cast by 4,324,964 shares (57.1% of outstanding) on April 28, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-201408","json":"https://secwatch.observer/filing/0001193125-26-201408.json","markdown":"https://secwatch.observer/filing/0001193125-26-201408.md","text":"https://secwatch.observer/filing/0001193125-26-201408.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526201408/0001193125-26-201408-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526201408/d151139d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T00:12:16.582873+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"comparable_filings":[{"accession":"0001108524-26-000131","ticker":"CRM","company_name":"Salesforce, Inc.","filed_at":"2026-06-01T20:43:09+00:00","headline":"Salesforce shareholders approve 34M share equity plan increase, extend term to 2036, all directors re-elected","event_type":"other_material","sec_items":["5.07","5.02","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same SEC item: 5.07","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001108524-26-000131","json":"https://secwatch.observer/filing/0001108524-26-000131.json","markdown":"https://secwatch.observer/filing/0001108524-26-000131.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1108524/000110852426000131/0001108524-26-000131-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1108524/000110852426000131/crm-20260528.htm"},"side_by_side_evidence":null},{"accession":"0000908937-26-000015","ticker":"SIRI","company_name":"SIRIUS XM HOLDINGS INC.","filed_at":"2026-06-01T20:28:55+00:00","headline":"Sirius XM shareholders approve 7.2M share increase in 2024 equity plan, elect directors","event_type":"other_material","sec_items":["5.02","5.07","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same SEC item: 5.07","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000908937-26-000015","json":"https://secwatch.observer/filing/0000908937-26-000015.json","markdown":"https://secwatch.observer/filing/0000908937-26-000015.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/908937/000090893726000015/0000908937-26-000015-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/908937/000090893726000015/siri-20260528.htm"},"side_by_side_evidence":null},{"accession":"0001628280-26-039518","ticker":"ESPR","company_name":"Esperion Therapeutics, Inc.","filed_at":"2026-06-01T20:22:15+00:00","headline":"Esperion shareholders approve 7M-share increase to 2022 equity incentive plan","event_type":"other_material","sec_items":["5.02","5.07","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same SEC item: 5.07","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-039518","json":"https://secwatch.observer/filing/0001628280-26-039518.json","markdown":"https://secwatch.observer/filing/0001628280-26-039518.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1434868/000162828026039518/0001628280-26-039518-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1434868/000162828026039518/espr-20260528.htm"},"side_by_side_evidence":null},{"accession":"0000943374-26-000219","ticker":"DCOM","company_name":"Dime Community Bancshares, Inc. /NY/","filed_at":"2026-06-01T20:02:33+00:00","headline":"Dime Commercial Bancshares name change effective; three executives amend employment agreements","event_type":"other_material","sec_items":["5.02","5.03","5.07","9.01"],"materiality_score":0.55,"calibrated_materiality_score":0.55,"match_reasons":["same SEC item: 5.07","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000943374-26-000219","json":"https://secwatch.observer/filing/0000943374-26-000219.json","markdown":"https://secwatch.observer/filing/0000943374-26-000219.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/846617/000094337426000219/0000943374-26-000219-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/846617/000094337426000219/form8k_052826.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-249857","ticker":"AIRJ","company_name":"AirJoule Technologies Corp.","filed_at":"2026-06-01T12:34:22+00:00","headline":"AirJoule Technologies raises $15M in registered direct offering at $4.10/share","event_type":"other_material","sec_items":["1.01","5.07","7.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same SEC item: 5.07","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-249857","json":"https://secwatch.observer/filing/0001193125-26-249857.json","markdown":"https://secwatch.observer/filing/0001193125-26-249857.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1855474/000119312526249857/0001193125-26-249857-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1855474/000119312526249857/airj-20260528.htm"},"side_by_side_evidence":null},{"accession":"0001213900-26-063110","ticker":"RDAC","company_name":"Rising Dragon Acquisition Corp.","filed_at":"2026-06-01T10:08:35+00:00","headline":"Shareholders approve SPAC extension to Oct 15, 2027; ~1.9M shares redeemed","event_type":"other_material","sec_items":["1.01","5.03","5.07","8.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same SEC item: 5.07","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-063110","json":"https://secwatch.observer/filing/0001213900-26-063110.json","markdown":"https://secwatch.observer/filing/0001213900-26-063110.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2018145/000121390026063110/0001213900-26-063110-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2018145/000121390026063110/ea0292895-8k_rising.htm"},"side_by_side_evidence":null},{"accession":"0001021771-26-000084","ticker":"BRTX","company_name":"BioRestorative Therapies, Inc.","filed_at":"2026-05-29T21:07:05+00:00","headline":"BRTX shareholders approve 20x increase in authorized shares; CEO/CFO sign 3-year employment agreements","event_type":"other_material","sec_items":["5.02","5.07","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same SEC item: 5.07","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001021771-26-000084","json":"https://secwatch.observer/filing/0001021771-26-000084.json","markdown":"https://secwatch.observer/filing/0001021771-26-000084.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1505497/000102177126000084/0001021771-26-000084-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1505497/000102177126000084/brtx-20260529.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-248680","ticker":"TNYA","company_name":"Tenaya Therapeutics, Inc.","filed_at":"2026-05-29T21:04:54+00:00","headline":"Tenaya shareholders approve amended equity plan adding 6.5M shares, elect directors","event_type":"other_material","sec_items":["5.02","5.07","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same SEC item: 5.07","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-248680","json":"https://secwatch.observer/filing/0001193125-26-248680.json","markdown":"https://secwatch.observer/filing/0001193125-26-248680.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1858848/000119312526248680/0001193125-26-248680-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1858848/000119312526248680/tnya-20260527.htm"},"side_by_side_evidence":null}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}